2. 豪门国际

    Global
    关于豪门国际

    致力于纳米抗体创新药物研发

    关于豪门国际
    科研论文
    截止现在，豪门国际生物研发团队在具有重要影响力的期刊上发表研究论文多篇。
    2020-01-13
    Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potentia
    发表于:Journal of Nanobiotechnology. 2020 Jan 13;18(1):12
    查看更多内容
    2020-01-07
    Simultaneous Unlocking Optoelectronic and Interfacial Properties of C60 for Ultrasensitive Immunosensing by Coupling to Metal-Organic Framework
    发表于:Analtical Chemistry. 2020 Jan 7;92(1):983-990
    查看更多内容
    2019-11-05
    Blocking the PD-1-PD-L1 axis by a novel PD-1 specific nanobody expressed in yeast as a potential therapeutic for immunotherapy
    发表于:Biochemical and Biophysical Research Communications. 2019 Nov 5;519(2):267-273
    查看更多内容
    2019-10-16
    Construction of Anti-hPD-L1 HCAb Nb6 and in Situ124 Labeling for Noninvasive Detection of PD-L1 Expression in Human Bone Sarcoma
    发表于:Bioconjugate Chemistry. 2019 Oct 16;30(10):2614-2623
    查看更多内容
    2018-07-11
    Direct Immunoassay for Facile and Sensitive Detection of Small Molecule Aflatoxin B1 based on Nanobody
    发表于:Chemistry: A European journal. 2018 Jul 11;24(39):9869-9876
    查看更多内容
    2018-03-23
    Boosted Electrochemical Immunosensing of Genetically Modified Crop Markers Using Nanobody and Mesoporous Carbon
    发表于:ACS Sensors. 2018 Mar 23;3(3):684-691
    查看更多内容
    总计 24 1234